TIME Magazineさんのインスタグラム写真 - (TIME MagazineInstagram)「When Pfizer-BioNTech’s vaccine became the first authorized for use in the U.S., the good news came with a catch: the vaccine, the first of its kind using a new mRNA-based technology, needs to be stored at ultra-cold temperatures (-80°C to -60°C) until thawing just before being injected into people’s arms, writes Alice Park. But in the past few weeks, the U.S. Food and Drug Administration reviewed data submitted by the companies on the stability of the doses at normal freezer temperatures (-25°C to -15°C), and on Feb. 25, the agency issued new guidance that says the vaccine can be safely shipped and stored for up to two weeks at these relatively higher temperatures. While that’s a shorter time period than the six months that the vaccine can be stored in freezers reaching ultra-cold temperatures, the option could give more hospitals, doctors’ offices, pharmacies, and health clinics the flexibility they need to effectively store and administer doses of the vaccine. Read more at the link in bio. In this photograph: Holy Name Medical Center in Teaneck, N.J., received 975 doses of the Pfizer-BioNTech vaccine last December. Photograph by Danny Kim (@dannk53) for TIME」2月27日 7時28分